Alec Freyn | Principal Scientist
Moderna

I am a virologist interested in vaccine design and preclinical development of mRNA-lipid nanoparticle-based technologies. I have worked on two products that are currently in clinical trials: mRNA-1769 for use in preventing Orthopoxvirus infection and mRNA-1608 for therapeutic treatment of Herpes Simplex Viruses. I also provide virologic support for our Influenza and Hepatitis B programs and aided in preclinical development of those products. Additionally, I am interested in technology development and engineering of mRNA-LNP vaccines to improve their immunological and clinical qualities.